Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citalopram).
| Image |  |
|---|---|
| Description | scientific article published in February 2006 |
| Author/s |
author: Helge Refsum Espen Molden |
| Publication date | February 1, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |